Yükleniyor...

Eagle Pharmaceuticals Reaches Settlement Agreement With Dr. Reddy's Labs Related To BENDEKA

RTTNews | 699 gün önce

Eagle Pharmaceuticals Reaches Settlement Agreement With Dr. Reddy's Labs Related To BENDEKA

(RTTNews) - Eagle Pharmaceuticals, Inc. (EGRX) announced Wednesday that it has reached a settlement agreement with Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (RDY). Eagle had asserted its Orange Book-listed patents against Dr. Reddy's related to its new drug application referencing BENDEKA.

Under the settlement agreement, Dr. Reddy's has the right to market its product beginning November 17, 2027, or earlier based on certain circumstances.

The settlement agreement is confidential and subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice. The settlement with Dr. Reddy's follows Eagle's previously announced settlements with Hospira, Inc. and Accord Healthcare, Inc. related to their new drug applications referencing BENDEKA.

Etiketler: EGRX

read more

Bay Street Seen Opening With Negative Bias

Bay Street Seen Opening With Negative Bias

Canadian shares may open with a negative bias Tuesday morning as trade war heats up with Canada retaliating with tariffs on over $1 billion worth of US imports within hours of U.S. President Donald Trump's announcement that tariffs on goods and Canada and Mexico will become effective today.

RTTNews | 5s 20 dakika önce

TSMC Shares Gain On $100 Bln US Investment

TSMC Shares Gain On $100 Bln US Investment

Shares of Taiwan Semiconductor Manufacturing Co. or TSMC were gaining around 2 percent in the pre-market activity on the NYSE after the chipmaker announced its additional $100 billion investment in the United States to build five more facilities for advanced chip manufacturing, as part of the ongoing efforts in the country to boost artificial intelligence.

RTTNews | 6s 17 dakika önce

Eurozone Jobless Rate Steady At Record Low

Eurozone Jobless Rate Steady At Record Low

Euro area unemployment rate remained unchanged at a record low in January despite weaker economic activity, official data showed Tuesday. The jobless rate stood at 6.2 percent in January, unchanged from December, Eurostat reported. This was down from 6.5 percent in the same period last year. The expected rate was 6.3 percent.

RTTNews | 6s 48 dakika önce

FTSE 100 Modestly Lower In Cautious Trade

FTSE 100 Modestly Lower In Cautious Trade

The UK market is off early lows in late morning trade on Tuesday with investors largely making stock specific moves, reacting to quarterly earnings updates. Worries about trade war following new U.S. tariffs against China, Canada and Mexico taking effect today.

RTTNews | 7s 30 dakika önce

U.S. Dollar Falls On Weak U.S. Economic Data

U.S. Dollar Falls On Weak U.S. Economic Data

The U.S. dollar weakened against other major currencies in the European session on Tuesday, as traders' confidence was tempered by weak U.S. economic data.

RTTNews | 8s 6 dakika önce

CAC 40 Drifts Lower On Trade War Concerns; Thales Rises Sharply On Results

CAC 40 Drifts Lower On Trade War Concerns; Thales Rises Sharply On Results

French stocks are down firmly in negative territory Tuesday morning, with new U.S. tariffs on Canada, Mexico and China, and U.S. President Donald Trump's threat that he will impose reciprocal tariffs from early April, hurting sentiment.

RTTNews | 8s 31 dakika önce

Sensex, Nifty End With Modest Losses; IT And Auto Stocks Drag

Sensex, Nifty End With Modest Losses; IT And Auto Stocks Drag

Indian shares ended slightly lower on Tuesday amid concerns that U.S. President Donald Trump's "tariffs on steroids" agenda may keep inflation higher and could tip the global economy into recession.

RTTNews | 8s 43 dakika önce

U.S. Dollar Falls Against Majors

U.S. Dollar Falls Against Majors

The U.S. dollar weakened against other major currencies in the European session on Tuesday.

RTTNews | 8s 45 dakika önce

Şartlar | Gizlilik | Site Haritası | Site Map Calendar

© 2025 Myfxbook Ltd. Her hakkı saklıdır.

YÜKSEK RİSK UYARI: Döviz trade’i, tüm yatırımcılar için uygun olmayabilecek yüksek düzeyde risk taşır. Kaldıraç, ek risk ve zarara maruz kalma yaratır. Döviz trade’i yapmaya karar vermeden önce yatırım hedeflerinizi, deneyim seviyenizi ve risk toleransınızı dikkatlice değerlendirin. İlk yatırımınızın bir kısmını veya tamamını kaybedebilirsiniz. Kaybetmeyi göze alamayacağınız parayla yatırım yapmayın. Döviz trade’i ile ilgili riskler konusunda kendinizi eğitin ve herhangi bir sorunuz varsa bağımsız bir finans veya vergi danışmanından tavsiye alın. Her türlü veri ve bilgi 'olduğu gibi' yalnızca bilgilendirme amaçlıdır ve trading amaçları veya tavsiye amaçlı değildir. Geçmiş performans gelecekteki sonuçların göstergesi değildir.